Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies.
Topp M, Dlugosz-Danecka M, Skotnicki AB, Salogub G, Viardot A, Klein AK, Hess G, Michel CS, Grosicki S, Gural A, Schwarz SE, Pietzko K, Gärtner U, Strassz A, Alland L, Mayer J.
Topp M, et al. Among authors: alland l.
Trials. 2023 Jan 3;24(1):4. doi: 10.1186/s13063-022-06982-7.
Trials. 2023.
PMID: 36597128
Free PMC article.
Clinical Trial.